Radiotherapy and immunotherapy: a beneficial liaison?
Investigations into the interaction between radiotherapy and the host immune system have
uncovered new mechanisms that can potentially be exploited to improve the efficacy of …
uncovered new mechanisms that can potentially be exploited to improve the efficacy of …
[HTML][HTML] Current progress in gene delivery technology based on chemical methods and nano-carriers
L Jin, X Zeng, M Liu, Y Deng, N He - Theranostics, 2014 - ncbi.nlm.nih.gov
Gene transfer methods are promising in the field of gene therapy. Current methods for gene
transfer include three major groups: viral, physical and chemical methods. This review …
transfer include three major groups: viral, physical and chemical methods. This review …
A phase 2 clinical trial assessing the efficacy and safety of pembrolizumab and radiotherapy in patients with metastatic triple‐negative breast cancer
Background The current study was conducted to evaluate the efficacy and safety of
pembrolizumab‐mediated programmed cell death protein 1 inhibition plus radiotherapy (RT) …
pembrolizumab‐mediated programmed cell death protein 1 inhibition plus radiotherapy (RT) …
Significance of tumor‐infiltrating lymphocytes before and after neoadjuvant therapy for rectal cancer
S Matsutani, M Shibutani, K Maeda… - Cancer …, 2018 - Wiley Online Library
Neoadjuvant therapy for locally advanced rectal cancer is becoming increasingly common.
However, biomarkers predicting the response to neoadjuvant therapy have not been …
However, biomarkers predicting the response to neoadjuvant therapy have not been …
[HTML][HTML] Tumor infiltrating lymphocytes (TILs) before and after neoadjuvant chemoradiotherapy and its clinical utility for rectal cancer
F Teng, D Mu, X Meng, L Kong, H Zhu… - American journal of …, 2015 - ncbi.nlm.nih.gov
Backgrounds: Radiotherapy (RT) and chemotherapy (CT) can potentiate systemic antitumor
immune effect. However, immunomodulation during RT or CT and their clinical implications …
immune effect. However, immunomodulation during RT or CT and their clinical implications …
Immunomodulatory effects of stereotactic body radiation therapy: preclinical insights and clinical opportunities
AE Marciscano, A Haimovitz-Friedman, P Lee… - International Journal of …, 2021 - Elsevier
Preclinical evidence suggests that stereotactic body radiation therapy (SBRT) is
immunomodulatory. Given the potential to augment local and systemic antitumor responses …
immunomodulatory. Given the potential to augment local and systemic antitumor responses …
Trial watch: anticancer radioimmunotherapy
E Vacchelli, I Vitale, E Tartour, A Eggermont… - …, 2013 - Taylor & Francis
Radiotherapy has extensively been employed as a curative or palliative intervention against
cancer throughout the last century, with a varying degree of success. For a long time, the …
cancer throughout the last century, with a varying degree of success. For a long time, the …
Current advances in immune checkpoint inhibitor combinations with radiation therapy or cryotherapy for breast cancer
Purpose Immune checkpoint inhibition (ICI) has demonstrated clinically significant efficacy
when combined with chemotherapy in triple negative breast cancer (TNBC). Although many …
when combined with chemotherapy in triple negative breast cancer (TNBC). Although many …
T cell exhaustion in cancer: mechanisms and clinical implications
JC Wang, Y Xu, ZM Huang, XJ Lu - Journal of cellular …, 2018 - Wiley Online Library
During chronic viral infection or cancer, the immune system usually induces a corresponding
immune response against pathogens or cancer cells so as to prevent worsening disease. T …
immune response against pathogens or cancer cells so as to prevent worsening disease. T …
Radiotherapy of human sarcoma promotes an intratumoral immune effector signature
A Sharma, B Bode, G Studer, H Moch… - Clinical Cancer …, 2013 - AACR
Purpose: The tumor immune microenvironment plays a crucial role in the development and
progression of cancer. Sarcomas are a group of heterogeneous soft tissue malignancies that …
progression of cancer. Sarcomas are a group of heterogeneous soft tissue malignancies that …